It's about what's next: Liver disease Cardiometabolic health Combination therapies The next generation of obesity innovation For IP leaders, this means new patent estates, new licensing opportunities, and new freedom-to-operate questions
Additional enhancements will leverage customer experiences and feedback
Advertisement Ask a Question 200 characters left Include your email address to get a message when this question is answered
This gene-regulatory capacity appears to be central to its observed effects, effectively recalibrating cellular activity towards a state of regeneration and homeostasis
GLP-1 medications work partly by suppressing appetite and slowing gastric emptying. That's the mechanism behind the weight loss. But less food in means fewer vitamins and minerals in and the research now shows this isn't a theoretical concern. Butsch et al. (2025), the largest of the six studies in the Urbina review, tracked 461,382 GLP-1 users and found 22.4% had a new nutritional deficiency diagnosis within 12 months. Vitamin D was most common (13.6%), followed by nutritional anemia (4%), iron deficiency (3.2%), and B vitamin deficiency (2.6%). In a smaller dietary study (Johnson et al. 2025, Frontiers in Nutrition), 64% of GLP-1 users didn't meet iron intake recommendations, and 72% fell short on calcium.* This GLP-1 supplement covers the five most at-risk nutrients with bioavailable forms: methylcobalamin B12, chelated iron, chelated zinc, 5-MTHF folate, and vitamin D3
